Bifogade filer
Kurs
+7,19%
Prenumeration
Kalender
Est. tid* | ||
2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-16 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2025-05-15 | - | Årsstämma |
2025-05-12 | - | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-22 | - | Kvartalsrapport 2024-Q2 |
2024-05-15 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2024-05-14 | - | Årsstämma |
2024-05-14 | - | Kvartalsrapport 2024-Q1 |
2024-02-21 | - | Extra Bolagsstämma 2024 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-09-28 | - | Extra Bolagsstämma 2023 |
2023-08-31 | - | Kvartalsrapport 2023-Q2 |
2023-05-12 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2023-05-11 | - | Årsstämma |
2023-05-11 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-12-09 | - | Extra Bolagsstämma 2022 |
2022-11-16 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2022-05-11 | - | Årsstämma |
2022-05-11 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-23 | - | Extra Bolagsstämma 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-08-11 | - | Extra Bolagsstämma 2020 |
2020-05-15 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2020-05-14 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-21 | - | Kvartalsrapport 2019-Q2 |
2019-08-16 | - | Extra Bolagsstämma 2019 |
2019-05-17 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2019-05-16 | - | Årsstämma |
2019-05-16 | - | Kvartalsrapport 2019-Q1 |
2019-02-20 | - | Bokslutskommuniké 2018 |
2018-11-14 | - | Kvartalsrapport 2018-Q3 |
2018-08-21 | - | Kvartalsrapport 2018-Q2 |
2018-05-24 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2018-05-23 | - | Årsstämma |
2018-05-23 | - | Kvartalsrapport 2018-Q1 |
2018-02-26 | - | Bokslutskommuniké 2017 |
2017-11-14 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-26 | - | X-dag ordinarie utdelning ACARIX 0.00 SEK |
2017-05-24 | - | Årsstämma |
2017-05-24 | - | Kvartalsrapport 2017-Q1 |
2017-02-23 | - | Bokslutskommuniké 2016 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Press release (MAR)
Malmö, November 12, 2020
Correction: Interim report 2020-01-01 to 2020-09-30
In the interim report that Acarix submitted today, 12 November 2020, there is a minor error under the heading “Capitalization” (page 4 in the interim report) where the last sentence is to end with 2022 and nothing else.
The correct sentence reads: " The Board assesses that cash balance as of the balance sheet date will cover the Company’s working capital requirements until the second quarter of 2022."
A corrected version of the interim report is available at www.acarix.se
For further information, please contact:
Per Persson, CEO
mail: per.persson@acarix.comtel:
+46 736 005 990
Christian Lindholm, CFO
mail: christian.lindholm@acarix.com
+46 705 118 333
The information disclosed above is mandatory for Acarix AB (publ) to publish pursuant to the EU Market Abuse Regulation. This information was submitted for publication through the agency of the above contact person on November 12, 2020 at 13:00 am (CET).
About Acarix
Acarix was established in 2009 and is listed on Nasdaq First North Premier. Acarix’s CADScor®System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-one system in the sense that the heart signal will be recorded, processed and displayed as a patient specific score, the CAD score, on the device screen. Readings are obtained in less than 8 minutes. Safe and suitable for use in both out- and inpatient settings, the CADScor®System thus has the potential to play a major role in patient triage, avoiding the need for many patients to undergo stressful and invasive diagnostic procedures.